# A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food

> **NCT05498701** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tafamidis free acid tablet (Test)
- **DRUG:** Tafamidis meglumine capsule (Reference)

## Key facts

- **NCT ID:** NCT05498701
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-29
- **Primary completion:** 2022-12-18
- **Final completion:** 2022-12-19
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05498701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05498701, "A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05498701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*